NICE has decided not to recommend the use of cannabis-based medicines in severe treatment-resistant epilepsy.
A new Canadian study reports that psychiatric conditions may emerge five years before the diagnosis of inflammatory diseases
Beta-interferons produce “a significant survival advantage among people with relapsing-onset multiple sclerosis” (RRMS), according to a new study
This module is about multiple sclerosis and identifying the symptoms.
The reclassification of cannabis-based medicines was a big story in 2018. Here we look at some questions following on from the move
A new report raises the prospect that multiple sclerosis might soon be ‘preventable or functionally curable’
Experts are encouraging people with multiple sclerosis to access vital health services through a new campaign.